Видео ютуба по тегу Prognostic Marker

MITO-16a/MANGO-OV2a: plasma TF as a prognostic marker in ovarian cancer
MITO-16a/MANGO-OV2a: plasma TF as a prognostic marker in ovarian cancer
ANITA: baseline cytokine profiling as a prognostic marker in recurrent ovarian cancer
ANITA: baseline cytokine profiling as a prognostic marker in recurrent ovarian cancer
Molecular MRD as a prognostic marker for AML patients with mutated CEBPA
Molecular MRD as a prognostic marker for AML patients with mutated CEBPA
Time to next treatment as a prognostic marker in patients with AL amyloidosis
Time to next treatment as a prognostic marker in patients with AL amyloidosis
Assessing metabolic tumor volume as a prognostic marker before CAR-T therapy for DLBCL
Assessing metabolic tumor volume as a prognostic marker before CAR-T therapy for DLBCL
VALENTINO: VAF as prognostic marker in mCRC
VALENTINO: VAF as prognostic marker in mCRC
Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer
Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer
Audioslides Lp-PLA2 - a Prognostic Marker of Coronary Events
Audioslides Lp-PLA2 - a Prognostic Marker of Coronary Events
Validation of the Immunoscore as a Prognostic Marker in Colon Cancer
Validation of the Immunoscore as a Prognostic Marker in Colon Cancer
Prognostic and Predictive Markers in Colorectal Cancer
Prognostic and Predictive Markers in Colorectal Cancer
Circulating tumor HPV-DNA as a prognostic marker for patients with oropharyngeal cancer
Circulating tumor HPV-DNA as a prognostic marker for patients with oropharyngeal cancer
MRD: a prognostic marker in targeted therapy
MRD: a prognostic marker in targeted therapy
New Diagnostic and Prognostic Markers for Melanoma.wmv
New Diagnostic and Prognostic Markers for Melanoma.wmv
POD36 as a prognostic marker and clinical tool in frontline CLL
POD36 as a prognostic marker and clinical tool in frontline CLL
Use of Novel Prognostic Markers in Practice for CLL
Use of Novel Prognostic Markers in Practice for CLL
Dr. Furman on Prognostic Markers in High-Risk CLL
Dr. Furman on Prognostic Markers in High-Risk CLL
Established and Emerging Prognostic Markers in Prostate Pathology
Established and Emerging Prognostic Markers in Prostate Pathology
TGFBI is a potential prognostic marker for bladder cancer - Video abstract [ID 208984]
TGFBI is a potential prognostic marker for bladder cancer - Video abstract [ID 208984]
Dr. Sonpavde on Novel Prognostic Marker for Atezolizumab in Bladder Cancer
Dr. Sonpavde on Novel Prognostic Marker for Atezolizumab in Bladder Cancer
Vida Talebian - Discovery of a prognostic marker in early ER+ breast cancer patients (TEAM trial)
Vida Talebian - Discovery of a prognostic marker in early ER+ breast cancer patients (TEAM trial)
CTC subtypes: A prognostic marker in GU cancer patients?
CTC subtypes: A prognostic marker in GU cancer patients?
Prognostic markers for CLL - how do they help determine who gets which treatment?
Prognostic markers for CLL - how do they help determine who gets which treatment?
Prognostic markers and MRD in CLL
Prognostic markers and MRD in CLL
Serum BCMA: a new prognostic marker for PFS in myeloma
Serum BCMA: a new prognostic marker for PFS in myeloma
Searching for Prognostic Markers in Patients with Osteosarcoma
Searching for Prognostic Markers in Patients with Osteosarcoma